Cannabis for Symptom Relief in HIV and Cancer: A Map of What We Know—and What We Don’t
Comments Off on Cannabis for Symptom Relief in HIV and Cancer: A Map of What We Know—and What We Don’t
March 26, 2026
Cannabis symptom management HIV cancer is an emerging field with limited but growing observational evidence. This review highlights gaps in dosing, safety, and effectiveness data. Patients and clinicians face uncertainty while seeking symptom relief…
Endocannabinoid System Research: Cannabis & HIV Smoking
Comments Off on Endocannabinoid System Research: Cannabis & HIV Smoking
March 4, 2026
Digital therapeutics tailored to people living with HIV show promising feasibility and acceptability as a scalable approach to smoking cessation. Tobacco use remains a leading driver of preventable illness and death among people with HIV, making…
Cannabinoid Clinical Trials: Digital Smoking Cessation for HIV
Comments Off on Cannabinoid Clinical Trials: Digital Smoking Cessation for HIV
March 3, 2026
This pilot trial evaluates digital therapeutics smoking cessation HIV interventions tailored for people living with HIV. The study shows strong feasibility and acceptability of app-based cessation tools in this population. Digital therapeutics offer a…